Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates

<p>– Expanded executive team as Lourie Zak appointed Chief Financial Officer –  – Extended clinical focus on systemic administration in small cell lung cancer – – $29.9 million in cash and equivalents – WESTLAKE VILLAGE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) —  Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third […]</p>
<p>The post <a href="https://forextv.com/top-news/genelux-corporation-reports-third-quarter-2023-financial-results-and-provides-general-business-updates/">Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>